USDA’s APHIS Updates Review Process for Petitions Seeking Nonregulated Status

The US Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) has announced updates to its practices for reviewing petitions seeking a determination of nonregulated status for certain organisms. This update is aimed at improving the efficiency and transparency of the review process. The new practices will apply to petitions for organisms that have been genetically engineered or otherwise altered to be resistant to certain pests or diseases. APHIS will now use a more streamlined approach to review these petitions, which will include a preliminary assessment of the potential risks and benefits associated with the organism. The agency will also provide more detailed guidance to petitioners on the types of information that are required to support a petition. Additionally, APHIS will make available a new template for petitioners to use when submitting their petitions. The updated practices are intended to reduce the burden on petitioners and to improve the overall quality of the review process. The changes are also expected to enhance the agency’s ability to make informed decisions about the regulation of these organisms. APHIS has stated that it will continue to ensure that any organisms that are determined to be nonregulated do not pose a risk to plant or animal health, or the environment. The agency will also continue to work closely with other federal agencies, such as the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA), to ensure that any regulatory decisions are consistent with the requirements of other federal laws. The updated practices are part of a broader effort by APHIS to improve its regulatory processes and to reduce the regulatory burden on stakeholders. The agency has also announced plans to conduct a review of its biotechnology regulations, which will include a consideration of the potential risks and benefits associated with genetically engineered organisms. This review is expected to be completed in the coming months and will provide an opportunity for stakeholders to provide input on the agency’s regulatory approach. Overall, the updates to APHIS’s practices for reviewing petitions seeking a determination of nonregulated status are an important step forward in improving the efficiency and transparency of the regulatory process. The changes are expected to benefit a wide range of stakeholders, including farmers, biotechnology companies, and environmental organizations. By providing more detailed guidance and streamlining the review process, APHIS is helping to ensure that the regulatory process is fair, efficient, and effective. The agency’s commitment to transparency and public engagement is also an important aspect of the updated practices, as it will help to build trust and confidence in the regulatory process. Furthermore, the updates are consistent with the agency’s mission to protect the health and well-being of people, animals, and plants, while also promoting agricultural productivity and competitiveness. The changes are also expected to have a positive impact on the environment, as they will help to reduce the risk of unintended consequences associated with the release of genetically engineered organisms. In conclusion, the updates to APHIS’s practices for reviewing petitions seeking a determination of nonregulated status are an important development in the regulation of biotechnology. The changes are expected to improve the efficiency and transparency of the regulatory process, while also promoting public engagement and trust in the agency’s decision-making processes.

Source